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Peptidylarginine deiminases (PAD) catalyze the conversion of arginine residues to citrullines. Five isoforms are
known that present distinct tissue locations. In the epidermis, like in the skin, only PAD1, 2, and 3 are expressed.
Their pattern of expression in skin appendages is not known. Here, confocal microscopy analysis using highly
specific antibodies demonstrated that PAD1 and 3 are expressed in human anagen hair follicles, PAD1 and 2, in
arrector pili muscles and sweat glands, whereas no PAD were detected in sebaceous glands. PAD1 was detected in
the cuticle and the Huxley layer of the inner root sheath (IRS), and in the companion layer. PAD3 was localized in
the medulla, and in the three layers of the IRS. Using anti-modiﬁed citrulline antibodies, we also showed that
deiminated proteins appeared in the lower part of the IRS, ﬁrst in the Henle layer, then in the cuticle, and ﬁnally in
the Huxley layer. Our data demonstrate that PAD3 is the enzyme that deiminates trichohyalin in the medulla and the
Henle layer, indicate that PAD1 and 3 are involved in the hair follicle program of differentiation, and suggest a role
for PAD1 and 2 in the physiology of sweat glands and arrector pili muscles.
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The peptidylarginine deiminase (PAD) enzymes (protein-
arginine deiminase, protein-L-arginine iminohydrolase, EC
3.5.3.15) are responsible for the formation of protein-bound
citrulline in the presence of calcium ions. First detected in
the hair follicles of the guinea-pig (Rogers and Taylor, 1977),
PAD activity has been identified in various tissues of almost
all vertebrates (for a review, see Vossenaar et al, 2003). Five
human PAD genes, clustered on chromosome 1p35–36,
have been described and named PADI1, 2, 3, 4, and 6 on
the basis of their cDNA nucleotide sequence and of the in
vitro biochemical features of their products: the PAD1, 2, 3,
4 (formerly named PAD type 5), and 6 (Nakashima et al,
1999; Rus’d et al, 1999; Kanno et al, 2000; Ishigami et al,
2002; Guerrin et al, 2003; Chavanas et al, 2004). PAD1 is
mainly found in the epidermis and uterus (Terakawa et al,
1991; Rus’d et al, 1999; Guerrin et al, 2003; Nachat et al,
2005). PAD2 is widely expressed in various tissues including
skeletal muscle, brain, uterus, salivary glands, pancreas,
and epidermis (Kubilus and Baden, 1985; Takahara et al,
1989; Watanabe and Senshu, 1989; Akiyama et al, 1990;
Terakawa et al, 1991; Ishigami et al, 2002; Nachat et al,
2005). PAD3 is expressed in the epidermis and hair follicles
(Terakawa et al, 1991; Rogers et al, 1997; Rus’d et al, 1999;
Kanno et al, 2000; Nachat et al, 2005). PAD4 is found in
hematopoietic cells (Nakashima et al, 1999; Asaga et al,
2001; Vossenaar et al, 2004). Human PAD6 mRNA were
mainly detected in ovary, peripheral blood leukocytes, and
testis (Chavanas et al, 2004). The structure of PAD4 deter-
mined after crystallization shows two elongated domains,
each with at least two calcium-binding sites. Calcium-bind-
ing induces conformational changes that generate the ac-
tive site cleft, formed by five b-strands. Moreover, PAD4
was shown to form a head-to-tail dimer (Arita et al, 2004).
Little is known about the exact functions and substrates
of PAD. Deimination dramatically alters the charge of argi-
nine residues from positive to neutral and results in the un-
folding of target proteins. Recently, the deimination of
histones by PAD4 was described as a novel mechanism for
antagonizing the transcription induction mediated by argi-
nine methylation (Cuthbert et al, 2004; Wang et al, 2004).
This post-translational modification has been implicated
in the pathogenesis of multiple sclerosis and rheumatoid
arthritis. Indeed, increased deimination of myelin basic pro-
tein and glial fibrillary acidic protein has been observed in
the brain of multiple sclerosis patients (Kim et al, 2003; Ni-
cholas et al, 2004). In rheumatoid arthritis, deiminated forms
of fibrin deposited in the rheumatoid synovial membranes
are the major target of disease-specific autoantibodies
(Masson-Bessie`re et al, 2001). In a Japanese population,
PADI4 gene polymorphisms were strongly linked to sus-
ceptibility to the rheumatic disease (Suzuki et al, 2003).
Moreover, a recent study revealed that PAD can act as an
autoantigen in patients with various inflammatory rheumatic
diseases (Nissinen et al, 2003).
Abbreviations: CDSN, corneodesmosin; DSG, desmoglein; HF, hair
follicles; IF, immunofluorescence; IRS, inner root sheath; MoAb,
monoclonal antibody; ORS, outer root sheath; PAD, peptidylargi-
nine deiminase; THH, trichohyalin
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In normal epidermis, where keratin K1 was identified as
the major deiminated epidermal protein, K10 and filaggrin
as the minor ones, the deiminated proteins are located in
the cornified layers, suggesting a role for PAD during the
terminal stages of epidermal differentiation (Senshu et al,
1995; Senshu et al, 1996). Deimination of filaggrin induces
its disassembly from keratin intermediate filaments, and
probably facilitates its proteolysis. This degradation gener-
ates a pool of amino acids that contribute to the cutaneous
natural moisturizing factor (Rawlings and Harding, 2004).
Alterations in the pattern of deiminated proteins in human
epidermis have been reported in some skin disorders,
namely psoriasis and bullous congenital ichthyosiform er-
ythroderma (Ishida-Yamamoto et al, 2000, 2002).
In the hair follicles (HF), trichohyalin (THH), a high mo-
lecular weight structural a-helix-rich protein of the inner root
sheath (IRS) and the medulla, is deiminated by PAD (Rogers
and Taylor, 1977). The following model of THH processing,
including its deimination, has been proposed. First, THH is
synthesized in the IRS keratinocytes as a large insoluble
protein-forming cytoplasmic granules. Then, deimination of
THH at the periphery of the granules generates a more sol-
uble form that is released and intermixed with keratin inter-
mediate filaments. THH is subsequently cross-linked by
transglutaminase 3 to itself and to keratins (Tarcsa et al,
1997; Steinert et al, 2003). In the medulla, which contains
few if any keratin intermediate filaments, the disperse THH
seems to be cross-linked as vacuolated aggregates en-
trapping air. But, the PAD isoforms used for THH deimina-
tion are unknown. Until now, only PAD3 has been detected
in HF. In situ hybridization and double immunofluorescence
(IF) staining revealed its co-expression with THH in wool
follicles of sheep and in human HF, respectively (Rogers
et al, 1997; Kanno et al, 2000). By RT-PCR experiments, we
recently demonstrated that three PADI genes are expressed
in human skin, i.e., PADI1, 2, and 3. Accordingly, using an-
tibodies highly specific for each PAD, we showed that
PAD1, 2, and 3 are actually expressed in the epidermis.
These results suggested that PAD other than PAD3 may be
expressed in HF. Here, we investigated the pattern of ex-
pression of these PAD in the human anagen HF and in other
skin appendages.
Results
By RT-PCR experiments, we previously demonstrated that
PADI1, 2, and 3 are the only PAD genes expressed in the
skin. In this study, we analyzed the expression of these
three PAD in human HF and skin appendages by indirect
IF and confocal microscopy using specific affinity purified
anti-peptide antibodies. Anagen HF were not stained with
the anti-PAD2(C2) antibodies (data not shown), but showed
clear expression of PAD1 and 3.
Localization of PAD1 in anagen HF Several distinct con-
centric compartments compose the HF: the outer root
sheath (ORS), which is the outermost layer, the IRS, and the
central hair shaft itself. The ORS and IRS are separated by
the companion layer. Three subcompartments further com-
posed the IRS: the Henle and Huxley layers, and the cuticle
in direct contact with the cuticle of the hair shaft. To precisely
localize PAD1 in the different layers of the HF, we performed
double-label IF staining using the anti-PAD1 antibodies
and two monoclonal antobodies (MoAb) directed to either
the desmosomal cadherins DSG1 and DSG2 (DG3.10) or
to corneodesmosin (CDSN), a corneodesmosomal protein
(G36-19). DG3.10 labeled the IRS from the stem cells to
the keratogenous zone, and part of the hair shaft (Fig 1A–C,
see also Fig 2A–D). As described (Mils et al, 1992), G36-19
Figure1
Expression of peptidylarginine deiminase type 1 (PAD1) in hair fol-
licles. Cryosections of human scalp were analyzed by indirect immuno-
fluorescence (double staining) and confocal observations with DG3-10,
a monoclonal antibody directed against desmoglein 1 and 2 (DSG1-2),
G36-19, a monoclonal antibody directed against corneodesmosin
(CDSN), and with affinity-purified anti-PAD1 antibodies. (A) A longitu-
dinal section of a hair follicle double stained with the anti-PAD1 and
DG3.10 antibodies. (B, C) Higher magnification of parts of the section
shown in (A). (D–F) A transverse section of a hair follicle stained with
G36-19 and anti-PAD1 antibodies. (F) Image superimposition of CDSN/
PAD1 labeling. The red arrow in (A) and the double-headed red arrows
in (A) and (B) denote the site of abrupt cornification of Henle and Huxley
layers, respectively. The white open arrowhead in (A) shows a stained
Flu¨gelzellen cell. He, Henle layer; He, cornified Henle layer; Hu, Huxley
layer; iCu, IRS cuticle; cl, companion layer; dp, dermal papilla. Scale
bar¼150 mm (A), ¼75 mm (B), and ¼ 50 mm (C–F).
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also stained the IRS, but the labeling appeared first (from the
base of the HF) in the Henle layer, then in the IRS cuticle, and
finally in the Huxley layer. It persisted in the three layers up to
the isthmus (Fig 1D, see also Fig 3A).
PAD1 was detected first in the IRS cuticle at the height of
the dermal papilla, then in the Huxley layer (Fig 1A and C),
and finally, in the middle portion of the HF, in the companion
layer (Fig 1B). PAD1 persisted in the cornified Huxley layer,
characterized by the abrupt disappearance of DG3.10
staining (Fig 1A and B). Double-label IF staining using an-
ti-PAD1 and G36-19 antibodies on transversal sections
(Fig 1D–F) revealed that in the upper portion of the HF, PAD1
was restricted to the companion layer. PAD1 expression
was also observed in cells of the Huxley layer that devel-
oped pseudopodal extensions passing through the corni-
fied Henle layer (Fig 1A, triangle). These cells probably
correspond to the specialized so-called Flu¨gelzellen cells
(Langbein et al, 2003). In every case, the labeling produced
by the anti-PAD1 was cytoplasmic.
Localization of PAD3 in anagen HF We performed dou-
ble-label IF staining using the anti-PAD3(B3) antibodies and
the MoAb DG3.10, G36-19, and AE16. AE16 is known to
label the THH granules of the IRS and the medulla of the HF
but not to react with THH when it is associated with the IRS
filaments (O’Guin et al, 1992).
Double-label IF using the anti-PAD3(B3) and DG3.10 an-
tibodies revealed cytoplasmic expression of PAD3 in the
Henle and Huxley layers and in the cuticle of the IRS, in
the bulb region (Fig 2A and B). Then, the labeling of the
Henle layer abruptly disappeared, as observed on longitu-
dinal (Fig 2A) and transversal (Fig 2C) sections of HF. Finally,
PAD3 was no longer detected in the cornified Huxley lay-
er characterized by the disappearance of DG3.10 staining
(Fig 2A and D). A higher magnification showed that the
labeling in the Huxley layer was granular. In some cases,
only the periphery of the granules seemed to be stained
(Fig 2E, arrows). Fig 2A, G, and F show that PAD3 is also
expressed in the Flu¨gelzellen cells and in the medulla,
respectively.
Double-label IF staining on longitudinal and transversal
sections of HF, using the anti-PAD3(B3) and G36-19, anti-
bodies showed that the loss of PAD3 detection in the IRS
coincided with the appearance of CDSN expression, first in
the Henle layer (Fig 3A and C), then in the cuticle, and finally
in the Huxley layer (Fig 3A and D). Therefore, disappearance
of anti-PAD3(B3) staining corresponded to the asynchro-
nous onset of abrupt cornification of these three layers.
Double-label IF staining on tangential sections of HF,
using the anti-PAD3(B3) and AE16 antibodies, showed that
the onset of AE16 labeling nearly coincided with the disap-
pearance of PAD3 detection (Fig 4A–C). AE16 labeling ap-
peared abruptly in distinct cells, and then rapidly became
diffuse before its total disappearance (Fig 4B). This corre-
sponds to the dispersion of THH granules and the associ-
ation of THH with the IRS filaments (Rothnagel and Rogers,
Figure 2
Expression of peptidylarginine deimi-
nase type 3 (PAD3) and desmoglein 1
and 2 (DSG1-2) in hair follicles. Cryo-
sections of the human scalp were analy-
zed by indirect immunofluorescence
(double (A–D) or simple (E–G) staining)
and confocal observations with DG3-10
and/or affinity-purified anti-PAD3(B3) anti-
bodies. Longitudinal (A) and cross (B–D)
sections of hair follicles analyzed by dou-
ble staining are shown. The position of
each transverse section on the longitudi-
nal section is indicated as follows: 1—B,
2—C, 3—D. The red arrow and the dou-
ble-headed red arrows in (A) denote the
site of abrupt cornification of Henle and
Huxley layers, respectively. Note the con-
comitant abrupt disappearance of PAD3
detection. The arrows in E show the labe-
ling at the periphery of granules. The
white open arrowhead in (A), (C), and (G)
shows a PAD3-stained Flu¨gelzellen cell.
M, medulla; the other abbreviations are
the same as in Fig 1. Scale bar¼150 mm
(A and F), ¼ 75 mm (B–D), ¼50 mm (E),
and ¼ 10 mm (G).
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1986; O’Guin et al, 1992). In some cells, the anti-PAD3(B3)
and AE16 labelings were co-localized (Fig 4C).
Localization of PAD in other skin appendages: sweat
glands, sebaceous glands, and hair arrector pili mus-
cles Analysis of human scalp sections by indirect IF with
the anti-PAD antibodies showed the presence of PAD1 and
PAD2 but not of PAD3 in sweat glands or in the arrector pili
muscles, whereas no immunoreactivities were detected in
sebaceous glands (data not shown). We then performed
double-label IF staining using either the anti-PAD1 or anti-
PAD2(C2) antibodies and a MoAb specific to smooth muscle
a-actin (Figs 5 and 6). Both PAD1 and PAD2 were observed
to co-localize with a-actin in the arrector pili muscles
(Fig 5A–C and D–F, respectively) and in the myoepithelial
cells at the periphery of the sweat glands (Fig 6A–C and
D–F, respectively). Staining of the cytoplasm of the secre-
tory cells of sweat glands was also observed with the anti-
PAD1 and anti-PAD2(C2) antibodies (Fig 6A, C, D, and F).
Localization of deiminated proteins in anagen HF To
determine whether the presence of PAD in skin appendages
was associated with deimination of proteins, we performed
immunohistochemistry analyses using AMC, purified anti-
bodies specific to chemically modified citrullines, as previ-
ously published (Senshu et al, 1995). On longitudinal
sections of HF, AMC labeling appeared in the lower part
of the IRS, first in the Henle layer (Fig 7A), then in the IRS
cuticle, and finally in the Huxley layer (Fig 7B and C). The
labeling persisted in the IRS at the isthmus. The medulla
was also strongly labeled (Fig 7C). The detection of dei-
minated proteins coincided with the asynchronous onset of
abrupt cornification of the IRS Henle layer, cuticle, and
Huxley layer. These results are consistent with the distribu-
tion of citrulline in rat HF, as observed long ago using
a colorimetric reaction with Ehrlich reagent (Rogers, 1963).
No staining was observed in the ORS, sweat glands, seba-
ceous glands or arrector pili muscles (data not shown).
Discussion
PAD activity was first identified in the HF of the guinea-pig
(Rogers and Taylor, 1977) where THH was described as a
substrate for deimination. Since then, the existence of five
isoforms of PAD has been reported, but their tissue distri-
bution has yet to be explored in detail. By RT-PCR exper-
iments, we demonstrated that PADI1, 2, and 3 are the only
PADI genes expressed in skin (Nachat et al, 2005). In order
to identify the different PAD isoforms expressed in human
anagen HF and other skin appendages, we performed dou-
ble-label IF staining on unfixed cryosections of human scalp
epidermis using our previously described anti-PAD anti-
bodies highly specific to each of these isoforms (Guerrin
et al, 2003; Nachat et al, 2005)
In human anagen HF, we demonstrated the expression of
PAD1, in the Huxley layer and the cuticle of the IRS and in
the companion layer. We also confirmed the expression of
PAD3. Indeed, PAD3 was described as the hair follicle PAD,
the expression of its mRNA being very similar to that of THH
in the IRS and medulla of wool follicles of sheep, as shown
by in situ hybridization (Rogers et al, 1997). In agreement,
we showed that PAD3 expression, at the protein level, is
restricted to the IRS and to the medulla of human anagen
HF. These results somehow showed discrepancy with those
obtained by Kanno et al (2000), who reported expression
not only in the IRS and medulla but also in the ORS. A likely
explanation is that the treatment performed by Kanno and
coworkers with sodium citrate buffer to unmask antigenic
sites on fixed sections might have produced artifacts. Al-
ternatively, the anti-PAD3 antibodies they used could have
cross-reacted with another epidermal protein.
The companion layer was initially defined as the inner-
most layer of the ORS. Because the companion layer cells
Figure 3
Expression of peptidylarginine deiminase type 3 (PAD3) and corn-
eodesmosin (CDSN) in hair follicles. Cryosections of the human
scalp were analyzed by indirect immunofluorescence (double staining)
and confocal observations with the anti-PAD3(B3) and G36-19 anti-
bodies. Longitudinal (A) and transverse (B–D) sections are shown. The
position of each transverse section on the longitudinal section is in-
dicated as follows: 1—B, 2—C, 3—D. The red arrow and the double-
headed red arrows in (A) denote the site of abrupt cornification of Henle
and Huxley layers, respectively, accompanied by the abrupt disap-
pearance of PAD3 detection. The white open arrowheads in (A) show
stained Flu¨gelzellen cells. The abbreviations are the same as in Fig 1.
Scale bar¼ 150 mm (A) and ¼75 mm (B–D).
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display properties different from those of the adjacent ORS
cells and because their origin in the hair bulb is unrelated to
that of the ORS cells, Schweizer’group proposed that the
companion layer is an integral compartment of the IRS, and
contributes to the guidance of hair shaft growth (Winter et al,
1998). Our findings add a new biochemical argument to
support this view: IRS and companion layer cells but not
ORS cells express PAD.
The only PAD detected in the medulla and the IRS Henle
layer is PAD3. Therefore, it is this isoform that is responsible
for the THH deimination in these parts of the HF. In the IRS
cuticle and Huxley layer, PAD1 and PAD3 are expressed
simultaneously, suggesting that PAD1 may also be involved
in the deimination of THH. Similarly, we previously demon-
strated the co-location of PAD1, 3, and (pro)filaggrin in the
granular layer and lower stratum corneum of the epidermis,
and suggested that only one of the two enzymes or a com-
bination of the two might be involved in the deimination of
filaggrin (Nachat et al, 2005). The presence of PAD1 in the
cornified Huxley layer, however, suggests that deimination
of THH can be completed by this isoform after cornification.
PAD1 expression was also described in the superficial stra-
tum corneum, where we proposed that it is involved in the
deimination of keratin K1 (Nachat et al, 2005). Whether K1 is
also deiminated by PAD1 in the Huxley layer remains to be
explored.
To study the function of THH in the HF, three MoAb al-
lowed three distinct stages of maturation of the protein to
be defined: the AE15-stained form, which is found through-
out the THH granules; the AE16-stained form which is lo-
cated on the surface of the granules; and the AE17-stained
form, which is associated with the keratin intermediate fil-
aments (O’Guin et al, 1992). O’Guin et al proposed that
AE16 recognizes a modified form of THH in the process of
being released from the granules. Our results suggest that it
is the deimination of THH by PAD3 that generates its labe-
ling by AE16. In particular, detection of THH by AE16 co-
incides with the appearance of deiminated proteins.
Moreover, we were able to locate PAD3 at the periphery
of granules, probably THH granules, in the cytoplasm of
keratinocytes in the IRS. This is in agreement with the model
presented by Steinert’s group, in which insoluble cytoplas-
mic droplets of THH that are located in the IRS and the
medulla are initially modified by PAD, which converts THH
to a more soluble form, and allows subsequent cross-linking
by transglutaminase 3 (Tarcsa et al, 1997).
A mouse type-I keratin, KRT1-c29, specifically ex-
pressed in the IRS cells, was shown to be deiminated be-
fore being cross-linked to THH and other cornified cell
components (Steinert et al, 2003). Our data suggest that
KRT1-c29 and its human ortholog, the IRS-specific keratin
25Cirs3, are deiminated by PAD1 or 3.
Figure 4
Expression of peptidylarginine deimi-
nase type 3 (PAD3) and trichohyalin
(THH) in hair follicles. Cryosections of
the human scalp were analyzed by indi-
rect immunofluorescence with the anti-
PAD3(B3) and anti-THH AE-16 antibodies.
Staining with anti-PAD3(B3) (A) and AE-16
(B) of tangential sections of hair follicles.
(C) Image superimposition of THH/PAD3
labelings. The double-headed red arrows
in (A) denote the site of abrupt cornificat-
ion of Huxley (Hu) layer. The white arrows
show the co-location of PAD3 and THH.
Scale bar¼150 mm.
Figure 5
Expression of peptidylarginine deimi-
nase type 1 (PAD1) and type 2 (PAD2) in
arrector pili muscles. Cryosections of
human scalp were analyzed by indirect
immunofluorescence and confocal mi-
croscopy with anti-PAD1 (A), anti-
PAD2(C2) (D) and anti-a-actin (B and E)
antibodies. (C and F) Image superimposi-
tion of a-actin/PAD1 and a-actin/PAD2
labeling, respectively. Scale bar¼ 100 mm
(A–C) and ¼ 75 mm (D–E).
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As observed in the human epidermis, by confocal mi-
croscopy analysis (Nachat et al, 2005), the distribution of
PAD in the HF contrasts with the distribution of deiminated
proteins only detected in the cornified IRS and in the me-
dulla (Table I) (Steinert et al, 1969). The absence of immuno-
detection of PAD in the cornified layers is probably due to
epitope masking in these compact cell layers, which is well
known to occur in the cornified layer of the epidermis.
These data also suggest that PAD are activated during the
final stages of terminal differentiation of the different layers
of the IRS, e.g., by an increase of intracellular calcium con-
centration as proposed for the epidermis. Several calcium-
binding proteins expressed in human HF may be involved in
this control, such as THH itself (Fietz et al, 1993; Lee et al,
1993), calcyclin (Wood et al, 1991), CLED (Sun et al, 2000),
or proteins of the S100 family (Takizawa et al, 1999; Schmidt
et al, 2001).
We also detected PAD1 and 2 in arrector pili muscles
and sweat glands, both in secretory and myoepithelial cells.
PAD2 localization in sweat glands was in agreement with
a previous study on human skin using a serum directed
against rat-PAD2, whereas its detection in arrector pili mus-
cles was in apparent discrepancy (Urano et al, 1990). This
could be due to experimental differences, e.g., the fixation
step of cryosections with acetone used by Urano et al. De-
spite the expression of PAD in sweat glands and arrector pili
muscles, no deiminated proteins were detected using anti-
modified citrulline antibodies (Table I). Therefore, PAD may
be produced as inactive forms that could be activated
in particular events, like apoptosis (Asaga et al, 1998;
Mizoguchi et al, 1998) or hormonal stimulation. Whether
PAD expression or activation is modulated during the var-
ious phases of the HF cycle remains to be explored.
The production of anti-PAD specific antibodies allowed
us to define the pattern of PAD expression in human skin
appendages. The specific location of the enzymes and dei-
minated proteins in the IRS suggests a crucial role for de-
imination during terminal differentiation of HF. In particular,
PAD1 and 3 may be essential for controlling mechanical
resistance of the sheath due to the peripheral cell envelope
and cytoplasmic keratin filament network, through THH de-
imination and subsequent cross-linking.
Figure 6
Expression of peptidylarginine deimi-
nase type 1 (PAD1) and type 2 (PAD2) in
sweat glands. Cryosections of the hu-
man scalp were analyzed by indirect
immunofluorescence and confocal mi-
croscopy with anti-PAD1 (A), anti-
PAD2(C2) (D), and anti-a-actin (B and E)
antibodies. (C and F) Image superimposi-
tion of a-actin/PAD1 and a-actin/PAD2
labeling, respectively. Scale bar¼75 mm.
Figure 7
Location of deiminated proteins in hair follicles (HF). Longitudinal
cryosections of hair follicles were analyzed by immunoperoxidase with
AMC antibodies specific to chemically modified citrullines. Note the
appearance of deiminated proteins (red) first in the Henle layer (blue
arrows in A and B), then in the cuticle (double-headed blue arrows in B
and C) and finally in the Huxley layer (red arrows in B and C) of the inner
root sheath. Deiminated proteins were also localized in the medulla (M)
of the HF. Note the black pigment deposited in the hair follicles (A and
B). Scale bar¼ 100 mm.
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Materials and Methods
Antibodies The MoAb G36-19 directed to CDSN was produced
and characterized in our laboratory (Serre et al, 1991). DG3.10, a
MoAb directed to desmoglein 1 and 2 (DSG1 and DSG2), was
purchased from Progen Biotechnik GmbH (Heidelberg, Germany).
AE16, a MoAb directed to THH, was a kind gift from T. T. Sun
(O’Guin et al, 1992). Affinity-purified polyclonal antibodies directed
to PAD1, 2 and 3, anti-PAD1, anti-PAD2(C2), and anti-PAD3(B3)
were elicited in rabbits, and previously characterized (Guerrin et al,
2003; Nachat et al, 2005). AMC, a monospecific antibody to
chemically modified citrullines, was kindly given by N. Blaes,
T. Senshu and has already been described (Senshu et al, 1995).
The MoAb 1A4 directed to the smooth muscle a-actin was pur-
chased from Sigma Aldrich, St. Louis, Missouri.
Immunohistology All described studies concerning human tis-
sues/subjects were conducted in adherence with the Declaration
of Helsinki Principles, and in accordance with the ethical guidelines
of the University of Toulouse III and of the French Ministry of Re-
search and Technology. Indirect IF was performed on unfixed 5–7
mm thick cryosections of human scalp skin as previously described
(Nachat et al, 2005). In the case of double staining, the sections
were further incubated with MoAb AE16, DG3.10, 1A4, or G36-19
diluted to 2.5 mg per mL. Sections were observed under a confocal
laser microscope (LSM 410, Carl Zeiss, Oberkochen, Germany),
excited at 488 and 543 nm with Ar and HeNe lasers, respectively.
For negative controls, sections were incubated without primary
antibodies. For analyses of deiminated proteins, cryosections were
incubated in 0.0125% FeCl3, 2.3 M H2SO4, 1.5 M H3PO4, 0.25%
diacetyl monoxime, and 0.125% antipyrine (modification medium)
at 371C for 3 h to modify citrulline residues chemically (Senshu
et al, 1995). Immunoperoxidase staining of the modified proteins
was then performed with the AMC antibody diluted in PBS to 0.25
mg per mL for 1 h at 371C, and the Histostain-Plus kit (Zymed, San
Francisco, California) using aminoethyl carbazole as a chromo-
genic substrate. Sections were counterstained with hematoxylin.
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